Skip to main content

Table 1 Demographic, clinical and transfusion data by patient group

From: Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial

Variable

Group A (fluid restriction)

Group B (liberal fluid administration)

Number of pts, n

100

92

Age (years)

66.0 ± 7.9

65.5 ± 8.3

Female gender, n (%)

17 (17.0%)

16 (17.4%)

Weight (kg)

77.2 ± 11.5

75.5 ± 10.6

Height (cm)

167.0 ± 7.8

168.0 ± 7.7

BMI

27.6 ± 3.5

26.7 ± 3.1

BSA (m2)

1.84 ± 0.17

1.84 ± 0.16

NYHA I-II, n (%)

57 (57.0%)

55 (59.8%)

NYHA III-IV, n (%)

43 (43.0%)

37 (40.2%)

LVEF (%)

50.2 ± 10.2

48.6 ± 12.1

Diabetes , n (%)

21 (21.0%)

20 (21.7%)

COPD, n (%)

14 (14.0%)

12 (13.0%)

Preop. Hct (%)

40.2 ± 4.42

40.6 ± 3.87

CABG, n (%)

88 (88.0%)

79 (85.9%)

Number of grafts

2.8 ± 0.6

2.7 ± 0.6

AVR + CABG

4 (4%)

4 (4.3%)

AVR

5 (5%)

6 (6.5%)

MVR

3 (3%)

2 (2.1%)

ASD Repair

0 (0%)

1 (1.1%)

CPB time (min)

96.9 ± 22.6

93.1 ± 20.0

AOX (min)

69.2 ± 20.0

67.9 ± 19.2

Operation time (min)

243 ± 49.4

236 ± 47.1

PRC transfused (total)

113 (1.13 ± 1.15*)

176 (1.91 ± 1.35) ◇◇

PRC transfused in OR, n (mean ± SD)

31 (0.31 ± 0.71*)

111 (1.21 ± 3.15) ◇◇

PRC transfused in ICU, n (mean ± SD)

82 (0.82 ± 0.98*)

65 (0.71 ± 0.88)

Transfused pts, n (%)

62 (62.0%)

75 (81.5%) ◇◇

Transfused pts in OR, n (%)

19 (19.0%)

62 (67.4%) ◇◇

Transfused pts in ICU, n (%)

51 (51.0%)

42 (45.7%)

PRC/pt transfused in OR (mean ± SD)

1.63 ± 0.68 **

1.79 ± 0.70

PRC/pt transfused in ICU (mean ± SD)

1.61 ± 0.78 **

1.55 ± 0.63

Females transfused, n (%)

16 (94.1%)

16 (100.0%)

Pts receiving ≥ 4 PRC u (OR + ICU)

2 (2.0%)

13 (14.1%) â—‡

  1. * denotes mean ± SD for the distribution of PRC units/pt in total
  2. ** denotes mean ± SD for the distribution of PRC units per transfused patient
  3. â—‡ p < 0.001
  4. ◇◇ p < 0.0001